Pelliciari, D.H.S., Reis, C.R.A. and Bordini, C.A. (2024) “Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? – a pharmacoeconomic study”, Headache Medicine, 15(Supplement), p. 98. Available at: https://headachemedicine.com.br/hm/article/view/1230 (Accessed: 24 May 2026).